Two New Drugs Show Promising Results in Preventing Alzheimer’s Disease
Alzheimer’s disease is a disease that is affecting more and more people. In Spain, more than 800,000 people suffer from it.according to Alzheimer’s Association. Fortunately, however, there is a growing body of research on this and how to prevent it, such as a study that found that Fish oil is useful for people genetically predisposed to Alzheimer’s diseaseToday we will talk to you about another advancement made in relation to this disease.
Several studies have found different drugs that can stop this disease. One of them, collected by the magazine Scienceand conducted by researchers from the University of Pennsylvania, Stanford University and an international team of collaborators, demonstrates that one type a drug used to treat various types of cancersuch as melanoma, leukemia and breast cancer may also contribute neurodegenerative diseases.
This discovery came about as a result of the discovery that by blocking a certain enzyme could save memory and brain function in models that mimic Alzheimer’s disease. Thus, this drug will serve as a treatment early stages of neurodegenerative diseases.
This new discovery of inhibiting this enzyme could pave the way for larger studies to protect the brain from neurodegeneration, which can affect thinking, memory and language. Until now, advances in Alzheimer’s disease prevention have focused on controlling symptoms and slowing progression, but it was not yet known how to do this. stop or prevent the onset of a disease.
In turn, another study, also published in the same journal, is devoted to how Alzheimer’s disease can affect brain function. It was found that this brain function can change glucose metabolism, which will deplete the brain’s energy and have negative consequences for thinking and memory.
A group of neurobiologists from Knight Brain Resilience Initiative at Stanford Neuroscience Institute Wu Tsai developed studies dedicated to regulation of brain metabolismknown as kynurenine pathwayThey showed that by blocking the kynurenine pathway in laboratory mice with Alzheimer’s disease, they could improve or even restore cognitive function by restoring healthy brain metabolism.
The next step will be to test it on humans in the hopes of getting positive results and finding a cure for Alzheimer’s disease.
